AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Pancreatic Neuroendocrine Neoplasm

Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations NCT06041009n/a1 site๐Ÿ“ Jinan Qilu Hospital of Shandong University ยท Tests: Pancreatic elastase-1 in blood serum An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site๐Ÿ“ Padova Azienda Ospedaliera di Padova 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012NA1 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: 68Ga-SorB PET/CT Lenvatinib Plus Chemotherapy for pNET Liver Metastases NCT07835893Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Lenvatinib, Chemotherapy Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours NCT06121622n/a1 site๐Ÿ“ Milan IRCCS San Raffaele A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) NCT07492680Phase 258 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Atlanta Bristol-Myers Squibb ยท Tests: BMS-986504, Daraxonrasib, Nivolumab + Relatlimab FDC, Temozolomide, Pumitamig Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors NCT04074135Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: 68-Gallium DOTATATE Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients NCT03048266n/a1 site๐Ÿ“ Houston M.D. Anderson Cancer Center Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) NCT06141369NA1 site๐Ÿ“ Shanghai Shanghai Jiao Tong University School of Medicine ยท Tests: individualized mRNA neoantigen vaccine (mRNA-0523-L001) A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites๐Ÿ“ Clovis๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach Bristol-Myers Squibb ยท Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig DCEUS to Assess Treatment Response to PRRT in GEP-NET NCT07319416NA1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Vuebox Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs NCT07136701n/a2 sites๐Ÿ“ Jinan๐Ÿ“ Jinan Qilu Hospital of Shandong University IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites๐Ÿ“ St Louis๐Ÿ“ Houston๐Ÿ“ San Antonio ViroMissile, Inc. ยท Tests: IDOV-Immune (oncolytic vaccinia virus) Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT05379985Phase 1, Phase 221 sites๐Ÿ“ Orange๐Ÿ“ Santa Monica๐Ÿ“ Tampa Revolution Medicines, Inc. ยท Tests: RMC-6236 Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors NCT06016855Phase 41 site๐Ÿ“ Nashville Vanderbilt-Ingram Cancer Center ยท Tests: Tumor Debulking, Lutetium Lu 177 Dotatate, Computed Tomography, Magnetic Resonance Imaging, Copper Cu 64 Dotatate Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2ฮฑ Related Genetic Alterations (MK-6482-015) NCT04924075Phase 284 sites๐Ÿ“ Los Angeles๐Ÿ“ Chicago๐Ÿ“ Warrenville Merck Sharp & Dohme LLC ยท Tests: Belzutifan Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors NCT06663072Phase 11 site๐Ÿ“ Chicago University of Chicago ยท Tests: Fulvestrant, 177Lu-DOTATATE 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection NCT06503146Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: [18F]FAPI-74, [18F]FDG Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms NCT05746182n/a3 sites๐Ÿ“ Los Angeles๐Ÿ“ San Diego๐Ÿ“ San Francisco University of California, San Francisco ยท Tests: Hereditary Cancer Panel Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767NA13 sites๐Ÿ“ Anderlecht๐Ÿ“ Ghent๐Ÿ“ Wilrijk European Organisation for Research and Treatment of Cancer โ€ฆ ยท Tests: Stereotactic body radiotherapy, Palliative RT A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET) NCT06505395Phase 21 site๐Ÿ“ Beijing CSPC ZhongQi Pharmaceutical Technology Co., Ltd. ยท Tests: SYHX2008 injection, Sandostatin LAR@ 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis NCT06937112n/a1 site๐Ÿ“ Nanjing Nanjing First Hospital, Nanjing Medical University ยท Tests: PET-CT examination Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors NCT07552467n/a1 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: Specific PET imaging agents targeting LRRC15 Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients NCT06893783Phase 24 sites๐Ÿ“ Seoul๐Ÿ“ Seoul๐Ÿ“ Seoul Inkeun Park ยท Tests: Tarlatamab Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" NCT01365169NA1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Exercise Intervention, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring, Health Telemonitoring Nutrition Intervention for Pancreatic Cancer NCT07554560NA2 sites๐Ÿ“ Philadelphia๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: Structured Lipid Medical Food Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy NCT07274657NA1 site๐Ÿ“ Lyon GCS Ramsay Santรฉ pour l'Enseignement et la Recherche ยท Tests: SMI and 2D-SWE modes Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms NCT05243082NA1 site๐Ÿ“ Oslo Oslo University Hospital ยท Tests: Radio frequency ablation The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas NCT07285044Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Cancer Therapeutic Procedure, Cancer Therapeutic Procedure, Questionnaire Administration A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism NCT06881992Phase 313 sites๐Ÿ“ Chicago๐Ÿ“ Bethesda๐Ÿ“ Boston Rezolute ยท Tests: Ersodetug
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy